Huntington disease (HD) is an autosomal-dominant neurodegenerative disease characterized by cognitive disturbance, motor abnormalities, and psychiatric symptoms. It is an orphan disease that is inherited genetically and results in a progressive breakdown of the nerve cells.
As per a study by Swierzewski et al. titled “Huntington’s Disease Overview, Incidence and Prevalence of HD,” 1 in every 10,000 persons (that accounts for nearly 30,00 people) in the United States are living with Huntington’s disease.
The rise in the prevalence of Huntington’s disease forms the major driving forces behind the advancing Huntington’s disease market
Several companies such as Hoffmann-La Roche, EIP Pharma, Vaccinex, and SOM Biotech SL and others are in the process of developing multiple-stage products that have the potential to create a significant positive shift in the Huntington’s disease market Size.
For more details visit: https://www.delveinsight.com/blog/huntingtons-disease-market/